Mobility Center
Basel, Canton of Basel-City, 4031, Switzerland
NCT Number: NCT01607736
Older individuals suffer from falls and fear of falling. The purpose of this study was to determine the effectiveness of a novel virtual gait training on walking performance and fear of falling in older adults, and to evaluate the feasibility of the virtual gait training program. The investigators hypothesize that virtual gait training in older adults over a three week period will both improve gait parameters as measured by a GAITRite® electronic walkway system, and reduce their fear of falling as measured by the Falls Efficacy Scale-International version.
Looking for future studies?
Notify Me65 year and older
All sexes
Interventional
Not applicable
Basel, Canton of Basel-City, 4031, Switzerland
The objectives of this study are to determine the effectiveness of virtual gait training on walking performance and fear of falling in older adults and to evaluate the feasibility of the virtual gait training. This prospective interventional study plans to include twelve residents of senior assisted living facilities in Basel, Switzerland, aged 65 years or older with no severe physical or cognitive disabilities, and who had fallen at least once in the preceding 12 months. Each participant will complete 14 12-minute virtual gait training sessions within a three-week period. Gait parameters will be quantified with the GAITRite® electronic walkway system, and fear of falling evaluated with the Falls Efficacy Scale-International version. The investigators hypothesize that 14 virtual gait training sessions in older adults over a three week period will both improve gait parameters as measured by a GAITRite® electronic walkway system, and reduce their fear of falling as measured by the Falls Efficacy Scale-International version.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The intervention consisted of 12-minute virtual gait training sessions once daily for a total of 14 weekdays within a three-week period. The intervention video showed walking legs of a 30-year-old woman for female and a 46-year-old man for male participants. The video screen was adjusted in height such that it corresponded to the legs of the standing participant, with a mirror placed above it. Participants began the training session with a circa one minute of concentration on the upcoming intervention. Afterwards, the video was started. Participants were instructed to stand (when necessary, to sit) and observe the video and mirror, and to imagine themselves walking. Training sessions were supervised by a physical therapist who gave additional instructions and comments regarding participants' visual/kinesthetic imagination of themselves performing the observed movement. Verbal and physical reactions during training sessions were documented in written form and sometimes videotaped.
Time frame: Change from baseline in gait speed at 3 weeks
gait speed measure with GAITRite® electronic walkway system
Time frame: change from baseline at end of week 3
total score on Falls Efficacy Scale-International version
University Hospital, Basel, Switzerland
Other
Pilot Study of Effects of Virtual Gait Training on Walking Stability in Older Adults
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07546734
Aging, Aging Frailty
Rome, Italy
View Trial DetailsNCT03129269
Alzheimer Disease, Brain Diseases
Toulouse, France
View Trial DetailsNCT05411393
Activities of Daily Living, Frail Elderly
Gainesville, Florida, United States
View Trial DetailsNCT03746392
Brain Diseases, Cardiovascular Diseases
Seattle, Washington, United States
View Trial Details